Thu Mar 10, 2022 – 10:21 pm ESTThu Mar 10, 2022 – 10:51 pm EST
(LifeSiteNews) – A group of medical experts commended Swedish health officials for announcing sweeping restrictions on dangerous transgender drugs for minors, saying the move will help safeguard vulnerable children.
In updated guidelines last month, the Swedish National Board of Health and Welfare (NBHW) recommended “restraint” regarding cross-sex hormones and puberty blockers for children, pointing to significant side-effect risks and “uncertain science.”
Hormonal interventions will be now prohibited entirely for minors who develop gender dysphoria after the start of puberty, NBHW said, and otherwise may only be used in research settings or “exceptional cases.” Gender dysphoria is a mental illness due to a so-called “gender identity” at odds with an individual’s biological sex.
The risks of hormone drugs “outweigh the possible benefits,” the NBHW concluded. The agency had previously approved the drugs for gender-confused children in 2015.
The Society for Evidence-based Gender Medicine (SEGM), an international non-profit organization of more than 100 physicians and researchers, welcomed Sweden’s reversal as an “impressive step.”
The new guidance means that eligibility for “puberty blockers and cross-sex hormones in Sweden will be sharply curtailed,” the group
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
